Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma

LD McAllister, ND Doolittle, PE Guastadisegni… - …, 2000 - journals.lww.com
OBJECTIVE: Patients with non-acquired immunodeficiency syndrome-related primary central
nervous system lymphomas have the potential to achieve durable complete responses …

Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery

EA Neuwelt, PE Guastadisegni… - American journal …, 2005 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: In children, MR imaging abnormalities consistent with
leukoencephalopathy after treatment for hematologic malignancy do not correlate with …

[BOOK][B] Accuracy of memory for experimental pain: A sensory decision analysis

PE Guastadisegni - 1996 - search.proquest.com
Memory for cold pressor pain was assessed in 43 healthy males and females from three
ethnocultural groups: Caucasian, African American, and Hispanic. A sensory decision theory (…

[CITATION][C] Innovative intergenerational prevention programming for older adults and adolescents

PE Guastadisegni, JL Simon, J Neuwelt… - Journal of the …, 2000 - Wiley Online Library
JAGS JANUARY 2000-VOL. 48, NO. 1 LETTERS TO THE EDITOR 105 r= 0.42, P=. 029. N o
significant correlations with cognitive function were observed on the “Up-and-Go” test (Y=-…

Dementia, agitation, and care in the nursing home

…, DC Post, P Guastadisegni - Journal of the American …, 1993 - Wiley Online Library
Objective To examine the behavioral and functional problems of the cognitively impaired.
Design A survey of a cohort of residents from six nursing homes. Participants Subjects were …

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

…, T Iacovazzi, A Miglietta, A Guastadisegni… - Journal of …, 2000 - Elsevier
Background/Aims: Interferon alpha provides benefit in only a limited number of patients with
chronic anti-HBe-positive hepatitis B. The aim of this study was to verify the long-term …

Importance of dose intensity in neurooncology clinical trials: Summary Report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium

…, T Cloughesy, SL Eck, P Guastadisegni… - Neuro …, 2001 - academic.oup.com
Therapeutic options for the treatment of malignant brain tumors have been limited, in part,
because of the presence of the blood-brain barrier. For this reason, the Sixth Annual Meeting …

Proceedings of the American Psychological Association, Incorporated, for the legislative year 1998: Minutes of the Annual Meeting of the Council of Representatives …

RF Levant - American Psychologist, 1999 - psycnet.apa.org
… Cooper Paul E. Cooper William Samuel Cooper Amy L. Copeland Kimberly Gayle … William
Freeman Paul Edward Freeman Mark Harry Freeston Richard L. Frei Karen E. Freidlen Stacy …

Association, Incorporated, for the Legislative Year 1998

RF Levant - 1999 - search.proquest.com
… Cooper Paul E. Cooper William Samuel Cooper Amy L. Copeland Kimberly Gayle … William
Freeman Paul Edward Freeman Mark Harry Freeston Richard L. Frei Karen E. Freidlen Stacy …

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

…, E Sinisi, G Leandro, M Insalata, A Guastadisegni… - Journal of …, 2002 - Elsevier
Background/Aims: In this study, lamivudine–interferon (LAM/IFN) combination therapy was
compared to LAM monotherapy to verify if the combination treatment might improve efficacy …